Advanced Biliary Tract Carcinoma (DBCOND0063240)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05969860	At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients with Advanced Cancer	No drug interventions	health_services_research	2	recruiting
NCT05705492	Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Solid or or Metastatic Esophagogastric, Hepatopancreaticobiliary, or Lung Cancer	Olanzapine	supportive_care	2	recruiting
NCT01828034	First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma	Binimetinib Cisplatin Gemcitabine	treatment	1 / 2	completed
NCT05451290	Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer	Camrelizumab Gemcitabine Oxaliplatin Rivoceranib Tegafur	treatment	2	not_yet_recruiting
NCT05733000	CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors	Devimistat Fluorouracil Gemcitabine Hydroxychloroquine Lipoic acid	treatment	2	recruiting
NCT04550624	Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma	Lenvatinib Pembrolizumab	treatment	2	recruiting
NCT03704480	Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.	Durvalumab Tremelimumab	treatment	2	active_not_recruiting
NCT03092895	A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC	Camrelizumab Rivoceranib	treatment	2	completed